The influence of adalimumab on the expression profile of mRNAs and miRNAs related to the IL‐12 and IL‐ 23 signal paths

Abstract

This study was financed by the Medical University of Silesia in Katowice/Poland on the basis of decision no. KNW‐1‐029/N/6/O. This research was supported in part by PLGrid Infrastructure.

Consent of the Bioethics Commission of Medical University of Silesia in Katowice/Poland no KNW/0022/KB1/59/I/13/14. Informed consent was obtained from all of the patients recruited.

This article is protected by copyright. All rights reserved.

http://bit.ly/2HHsbTs